Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

BACKGROUND: Interleukin-6-receptor inhibitors like Tocilizumab and Satralizumab are showing promising results in the treatment of Neuromyelitis Optica spectrum disorder (NMOSD). We aimed to investigate the efficacy and safety of various Interleukin-6-receptor inhibitors in the management of NMO/NMOS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharel, Sanjeev, Shrestha, Suraj, Ojha, Rajeev, Guragain, Neha, Ghimire, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609802/
https://www.ncbi.nlm.nih.gov/pubmed/34814882
http://dx.doi.org/10.1186/s12883-021-02488-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609802/
https://www.ncbi.nlm.nih.gov/pubmed/34814882
http://dx.doi.org/10.1186/s12883-021-02488-y

Ejemplares similares